1Fung SK,Lok AS.Update on viral hepatitis in 2004.Curr Opin Gastroenterol,2005,21:300-307. 被引量：1
2van Zonneveld M,Honkoop P,Hansen BE,et al.Long-term follow-up of alpha-interferon treatment of patients with chronic hepatitis B.Hepatology,2004,39:804-810. 被引量：1
3Janssen HL,Gerken G,Carreno V,et al.Interferon alfa for chronic hepatitis B infection:increased efficacy of prolonged treatment.The European Concerted Action on Viral Hepatitis.Hepatology,1999,30:238-243. 被引量：1
4Craxi A,Di Bona D,Camma C.Interferon-alpha for HBeAg-positive chronic hepatitis B.J Hepatol,2003,39(Suppl 1):S99-105. 被引量：1
5Cooksley WG,Piratvisuth T,Lee SD,et al.Peginterferon α-2a (40kDa):an advance in the treatment of hepatitis B e antigen-positive chronic hepatitis B.J Virol Hepatitis,2003,10:298-305. 被引量：1
6Marcellin P,Lau GKK,Bonino F,et al.Peginterferon alfa-2a alone,lamivudine alone and the two in combination in patients with HbeAg-negative chronic hepatitis B.N Engl J Med,2004,351:32-43. 被引量：1
7Janssen HL,van Zonneveld M,Senturk H,et al.Pegylated interferon alfa-2b alone or in combination with lamivudine for HBeAg-postive chronic hepatitis B:a randomized trial.Lancet,2005,365:123-129. 被引量：1
8Chan HL,Leung NW,Hui AY,et al.A randomized,controlled trial of combination therapy for chronic hepatitis B:comparing pegylated interferon-alpha2b and lamivudine with lamivudine alone.Ann Intern Med,2005,142(4):240-250. 被引量：1
9Lok AS,Lai CL,Leung N,et al..Long-term safety of lamivudine treatment in patients with chronic hepatitis B.Gastroenterology,2003,125:1714-1722. 被引量：1
10Marcellin P,Chang TT,Lim SG,et al.Adefovir dipivoxil for the treatment of hepatitis B e antigen-positive chronic hepatitis B.N Engl J Med,2003,348(9):808-816. 被引量：1
